Dr Puneeth Iyengar speaks to ecancer at ASCO 2024 about results from NRG-LU002 - a randomised phase II/III trial of maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC).

He explains that patients with oligometastatic NSCLC after first line of systemic therapy were randomised to maintenance systemic therapy or maintenance systemic therapy versus local consolidative therapy.

Dr Iyengar reports that there was no difference between the two arms suggesting that we should not routinely use radiation with systemic therapy aside from potential case by case situations.